Experience

Davis Polk advised Equinix, Inc. on its SEC-registered follow-on public offering of 2,985,575 shares of common stock including 389,422 shares that the underwriters…

Davis Polk advised the joint book-running managers in connection with a $60 million SEC-registered common stock and pre-funded warrants offering by Aeglea BioTherapeutics, Inc. The common…

Davis Polk advised Equinix, Inc. in connection with its SEC-registered at-the-market offering of its shares of common stock for up to an aggregate amount of $750 million. Equinix, Inc…

Davis Polk advised the book-running manager and representative of the underwriters in connection with the initial public offering by Taiwan Liposome Company, Ltd. of American Depositary…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $290 million initial public offering by Elastic N.V. The IPO consisted of a…

Davis Polk advised the underwriters in connection with the $90 million initial public offering of common stock by Kodiak Sciences Inc. The common stock is listed on the NASDAQ Global Market…

Davis Polk advised the underwriters in connection with an initial public offering of 18,000,000 shares of common stock of Bloom Energy Corporation at $15.00 per share, for total gross…

Davis Polk advised the representatives of the underwriters in connection with the follow-on offering of 5,175,000 shares of common stock for Natera, Inc. for total gross proceeds of …

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $200 million aggregate principal amount of 4.150% notes due 2048. The 4.150% notes due 2048…

Davis Polk advised the joint book-running managers in connection with the $86.25 million public offering of common stock of Coherus BioSciences, Inc. Based in Redwood City, California,…